source
- New evidence links AAV gene therapies to tumor risk, raising safety concernsRecent cases reported this year provide strong evidence that adeno-associated viruses (AAVs), the vectors used to deliver therapeutic genes, can trigger tumor formation. The findings settle a two‑d…
- Novartis reports seven tumor cases in children treated with ZolgensmaNovartis has disclosed that seven children who received its gene therapy Zolgensma for spinal muscular atrophy were later found to have tumors. The company said the cases were identified during po…